In summary, the downregulation of PPP2R1A by PAX3-FOXO1 fusion protein plays an important role in the acquisition of malignant potential in ARMS cells with PAX3-FOXO1 fusion. This evidence concerns the gene PAX3 and alveolar rhabdomyosarcoma.